The Current Ratio as of November 2025 (TTM) for Opiant Pharmaceuticals, Inc. (OPNT) is 10.10

According to Opiant Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.10. This represents a change of 19.36% compared to the average of 8.46 of the last 4 quarters.

Opiant Pharmaceuticals, Inc. (OPNT) Historical Current Ratio (quarterly & annually)

How has OPNT Current Ratio performed in the past?

The mean historical Current Ratio of Opiant Pharmaceuticals, Inc. over the last ten years is 3.33. The current 10.10 Current Ratio has changed 30.21% with respect to the historical average. Over the past ten years (40 quarters), OPNT's Current Ratio was at its highest in in the June 2021 quarter at 10.46. The Current Ratio was at its lowest in in the October 2012 quarter at 0.00.

Opiant Pharmaceuticals, Inc. (OPNT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Opiant Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Opiant Pharmaceuticals, Inc. (OPNT) Average Current Ratio

How has OPNT Current Ratio performed in the past?

The current Current Ratio of Opiant Pharmaceuticals, Inc. (OPNT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Opiant Pharmaceuticals, Inc. (OPNT) Current Ratio vs. Peers

How is OPNT’s Current Ratio compared to its peers?

Opiant Pharmaceuticals, Inc.’s Current Ratio is less than Cyteir Therapeutics, Inc. (28.07), greater than RVL Pharmaceuticals plc (2.89), less than HilleVax, Inc. (26.39), less than Tourmaline Bio, Inc. (24.68), greater than Jounce Therapeutics, Inc. (8.37), greater than Miromatrix Medical Inc. (5.52), greater than Decibel Therapeutics, Inc. (4.81), greater than Graybug Vision, Inc. (5.45), greater than Paratek Pharmaceuticals, Inc. (3.66), less than Aadi Bioscience, Inc. (20.41),

Build a custom stock screener for Opiant Pharmaceuticals, Inc. (OPNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opiant Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opiant Pharmaceuticals, Inc. (OPNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opiant Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.